论文部分内容阅读
目的 评价碱性成纤维细胞因子 (bFGF)滴眼液治疗外伤性角膜上皮缺损 (TCED)的临床疗效。方法 观察TCED 86例 (由化学烧伤、机械擦伤、手术等所致 ) ,随机分成bFGF治疗组和素高捷疗对照组各 43例。bFGF及素高捷疗均为每日滴眼 4次 ,疗程 14天 ,隔日观察上皮缺损修复和局部症状、体征等指标。结果 (1)两组各疗效判断指标治疗前差异均有显著性 (P <0 0 1) ;(2 )bFGF治疗角膜上皮疾病的有效率优于素高捷疗 (P <0 0 5 ) ;(3 )bFGF治疗化学烧伤、擦伤、手术和其它原因所引起的TCED的有效率分别为 88 9%、10 0 %、85 7%和 5 7 1% ;(4 )观察过程中未见局部刺激和全身不良反应。 (4 )观察过程中未见局部刺激和全身不良反应。结论 bFGF滴眼液治疗TCED疗效确切 ,安全性高。
Objective To evaluate the clinical efficacy of basic fibroblast factor (bFGF) eye drops in the treatment of traumatic corneal epithelial defects (TCED). Methods TCED 86 cases (caused by chemical burn, mechanical abrasion, surgery, etc.) were randomly divided into bFGF treatment group and control group, 43 cases each. bFGF and Supra were all treated with 4 drops daily for 14 days. The epithelial defects were repaired and local symptoms and signs were observed on the next day. Results (1) There was significant difference between the two groups before treatment (P <0.01); (2) The effective rate of bFGF in treating corneal epithelial disease was better than that of Suco (P <0.05). (3) The effective rate of bFGF in treating TCED caused by chemical burns, abrasions, surgeries and other causes was 88.9%, 100%, 857% and 571%, respectively; (4) No local Stimulation and systemic adverse reactions. (4) No local stimulation and systemic adverse reactions were observed during the observation. Conclusion bFGF eye drops treatment of TCED exact effect, high safety.